Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
CEND1 (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
CEND1 Involved in neuroblastoma cell differentiation. Homodimer. Neuron specific. Belongs to the CEND1 family. Note: This description may include information from UniProtKB.
Protein type: Membrane protein, integral
Cellular Component: integral to membrane
Biological Process: negative regulation of granule cell precursor proliferation; cerebellar Purkinje cell differentiation; adult walking behavior; cerebellar granular layer maturation; radial glia guided migration of granule cell
Reference #:  Q8N111 (UniProtKB)
Alt. Names/Synonyms: BM88; BM88 antigen; cell cycle exit and neuronal differentiation 1; Cell cycle exit and neuronal differentiation protein 1; CEND; CEND1; FLJ90066; MGC34326
Gene Symbols: CEND1
Molecular weight: 14,954 Da
Basal Isoelectric point: 9.24  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

CEND1

Protein Structure Not Found.


STRING  |  Wikipedia  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene  |  InnateDB


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 2 S7 _MESRGKSASsPKPD
0 1 S9 ESRGKSASsPKPDTK
0 3 S10-p SRGKSASsPKPDTKV
0 1 K12 GKSASsPKPDTKVPQ
0 1 T15 ASsPKPDTKVPQVTT
0 2 K25 PQVTTEAKVPPAADG
0 5 K38 DGKAPLTKPSKKEAP
0 3 K48 KKEAPAEKQQPPAAP
0 5 K61 APTTAPAKKTSAKAD
0 4 K62 PTTAPAKKTSAKADP
0 2 T63 TTAPAKKTSAKADPA
0 3 S86-p KPAPTVPssPDAtPE
0 4 S87-p PAPTVPssPDAtPEP
0 2 T91-p VPssPDAtPEPKGPG
0 1 P92 PssPDAtPEPKGPGD
0 1 A106 DGAEEDEAASGGPGG
  mouse

 
S7-p _MESRGKsAssPKPD
S9-p ESRGKsAssPKPDtK
S10-p SRGKsAssPKPDtKV
K12 GKsAssPKPDtKVPQ
T15-p AssPKPDtKVPQATA
K25-ub PQATAEAkATPAADG
K38 DGKAPLTKPVKKDTQ
K48-ub KKDTQAEkQEQAAAP
K61-ub APGPAATkktPAKAD
K62-ub PGPAATkktPAKADP
T63-p GPAATkktPAKADPV
S89-p PTVPAAPssPDAtsE
S90-p TVPAAPssPDAtsEP
T94-p APssPDAtsEPKGPG
S95-p PssPDAtsEPKGPGD
S109-p DGAEEDEsNTGGRGP
  rat

 
S7 _MESRGKSASsPkPD
S9 ESRGKSASsPkPDTK
S10-p SRGKSASsPkPDTKV
K12-ub GKSASsPkPDTKVPQ
T15 ASsPkPDTKVPQATA
K25-ub PQATAEAkATPAADG
K38-ub DGKAPLTkPVKKDAQ
K48-ub KKDAQAEkQEQPAAP
K61-ub APGPATTkkTPAKAD
K62-ub PGPATTkkTPAKADP
T63 GPATTkkTPAKADPV
S89 PTVPAAPSsPDTTSE
S90-p TVPAAPSsPDTTSEP
T94 APSsPDTTSEPKGPG
S95 PSsPDTTSEPKGPGD
S109 DGAEEDESNTGGRGP
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.